HOW TO TALK CKD
WITH PATIENTS
Having a conversation with your patients is an important step in slowing the progression of CKD and prolonging dialysis-free living. And, by talking to patients early, you can help them avoid surprises later. So when you see a decline in eGFR, kick off the conversation.
ERA endorsement is for the promotion of education in general, therefore the specific content of this material is the responsibility of AstraZeneca.
Declared by Primary Care Diabetes Europe (PCDE) in the scientific or social interest of primary care practitioners.
YOU CAN MAKE A DIFFERENCE.
DIAGNOSE AND DISCUSS.
Our Patient Counselling Resource was created with input from patients and can help guide the conversation with patient-friendly language and simple, proactive actions they take to improve their kidney health.
“No one had ever talked to me about CKD.”
LEARN THE IMPORTANCE OF DIAGNOSING CKD EARLY FROM LEADING EXPERTS
WATCH THE PRESSURE IS ON WEBCAST VIDEO
The Pressure Is On – LIVE WEBCAST
Diagnosing and Improving Outcomes in CKD
CKD can be life-threatening condition that is vastly underdiagnosed. This webcast will provide medical education on disease state awareness to support the diagnosis of CKD and improve patient outcomes. Join leading experts to learn about the importance of diagnosing CKD early.
CKD, chronic kidney disease; CV, cardiovascular; eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate.
References
- Ryan TP et al. Am J Med. 2007;120(11):981–986.
- Ravera M et al. Am J Kidney Dis. 2011;57(1):71–77.
- GBD Chronic Kidney Disease Collaboration, Lancet. 2020;395(10225):709–733.
- Alabama Department of Public Health. Special Task Force on Chronic Kidney Disease report. April 2007. Accessed 20 November 2020.
https://kipdf.com/special-task-force-on-chronic-kidney-disease-report-april-2007_5ad9b5767f8b9a9b248b45be.html - Kidney Disease: The Basics. National Kidney Foundation. Published 5 April 2021. Accessed 4 February 2022.
https://www.kidney.org/sites/default/files/web_kidneybasics_v4.pdf - Brenner BM et al. N Engl J Med. 2001;345(12):861–869.
- Go AS et al. N Engl J Med. 2004;351(13):1296–1305.
- Levin A et al. Kidney Int. 2014;85(1):49–61.
- Estimated glomerular filtration rate (eGFR). National Kidney Foundation. Reviewed 14 September 2020. Accessed 25 November 2020.
https://www.kidney.org/atoz/content/gfr - Ghaderian SB et al. J Renal Inj Prev. 2014;3(4):109–110.
- Couser WG et al. Kidney Int. 2011;80(12):1258–1270.
- Measurement and estimation of kidney function. Abdominal Key. Accessed 2 November 2021.
https://abdominalkey.com/measurement-and-estimation-of-kidney-function/ - Alyshah AS et al. REVEAL-CKD: Prevalence of and Patient Characteristics Associated With Undiagnosed Stage 3 Chronic Kidney Disease. Poster number: PO2337. Presented at: the American Diabetes Association 81st Scientific Sessions, 25–29 June 2021 (virtual).
- Kidney Disease Stats. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. December 2016. Accessed 25 November 2020.
https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease - Yacoub R, Habib H, Lahdo A, et al. Association between smoking and chronic kidney disease: A case control study. BMC Public Health. 2010;10:731.
- Schnaper HW. Pediatr Nephrol. 2014;29(2):193–202.